Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III

Esther Gonzalez Cantalapiedra

Sonia Martínez González

Jose Ignacio Martín Hernando

Joaquín Pastor Fernández

Antonio Rodríguez Hergueta

Carmen Blanco Aparicio

Ana Maria Garcia Collazo

Francisco Javier Ramos Lima

Ana Isabel Hernández Higueras

Carl-Gustave Pierre Saluste

Antonio Salgado Serrano

Beatriz Noya Marino

Joaquin Pastor Fernandez

Jose Ignacio Martin Hernando

Ana Isabel Hernandez Higueras

Antonio Rodriguez Hergueta

There is provided compounds of formula (I), wherein R, R, Rand Rhave meanings given in the description (and which compounds are optionally substituted as indicated in the description), and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PIM family kinase, such as PIM-1, PIM-2 and/or PIM-3) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease. There is also provided combinations comprising the compounds of formula (I). 

Tricyclic compounds for use as kinase inhibitors

Growing community of inventors

Madrid, Spain

Esther Gonzalez Cantalapiedra